Lifecore Biomedical, Inc. (LFCR) Stock Overview
Explore Lifecore Biomedical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Lifecore Biomedical, Inc. (LFCR)
Key Financials
Key Financials
Market Cap
178.9M
P/E Ratio
-4.44
EPS (TTM)
$-1.07
ROE
-2.51%
LFCR Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Lifecore Biomedical, Inc. (NASDAQ: LFCR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Lifecore Biomedical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of LFCR on the NASDAQ shows an RSI of 52.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.24 for the NASDAQ listing.
Key metrics behind Lifecore Biomedical, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.44 and a market capitalization of 178.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LFCR on the NASDAQ.